Skip to main content

Research Repository

Advanced Search

People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function.

Mclaughlin, Marie; Sanal-Hayes, Nilihan E M; Hayes, Lawrence D; Berry, Ethan C; Sculthorpe, Nicholas F

People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function. Thumbnail


Authors

Marie Mclaughlin

Lawrence D Hayes

Ethan C Berry

Nicholas F Sculthorpe



Abstract

This study aimed to compare flow-mediated dilation values between individuals with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and healthy age-matched controls to assess the potential implications for clinical management and long-term health outcomes. A case-case-control approach was employed, and flow-mediated dilation measurements were obtained from 51 participants (17 Long COVID patients, 17 ME/CFS patients, and 17 healthy age-matched controls). Flow-mediated dilation values were analysed using one-way ANOVA for between-group comparisons. Results revealed significantly impaired endothelial function in both Long COVID and ME/CFS groups compared to healthy age-matched controls as determined by maximum % brachial artery diameter post-occlusion compared to pre-occlusion resting diameter (6.99 ± 4.33% and 6.60 ± 3.48% vs. 11.30 ± 4.44%, respectively, both p < 0.05). Notably, there was no difference in flow-mediated dilation between Long COVID and ME/CFS groups (p = 0.949), despite significantly longer illness duration in the ME/CFS group (ME/CFS: 16 ± 11.15 years vs. Long COVID: 1.36 ± 0.51 years, p < 0.0001). The study demonstrates that both Long COVID and ME/CFS patients exhibit similarly impaired endothelial function, indicating potential vascular involvement in the pathogenesis of these post-viral illnesses. The significant reduction in flow-mediated dilation values suggests an increased cardiovascular risk in these populations, warranting careful monitoring and the development of targeted interventions to improve endothelial function and mitigate long-term health implications. [Abstract copyright: Copyright © 2023. Published by Elsevier Inc.]

Citation

Mclaughlin, M., Sanal-Hayes, N. E. M., Hayes, L. D., Berry, E. C., & Sculthorpe, N. F. (in press). People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function. #Journal not on list, S0002-9343(23)00609-5. https://doi.org/10.1016/j.amjmed.2023.09.013

Journal Article Type Article
Acceptance Date Sep 28, 2023
Online Publication Date Oct 11, 2023
Deposit Date Oct 30, 2023
Publicly Available Date Oct 30, 2023
Journal The American Journal of Medicine
Peer Reviewed Peer Reviewed
Pages S0002-9343(23)00609-5
DOI https://doi.org/10.1016/j.amjmed.2023.09.013
Keywords Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Flow Mediated Dilation, Long-COVID

Files




You might also like



Downloadable Citations